Below are the most recent publications written about "Coronary Restenosis" by people in Profiles.
-
Merinopoulos I, Gunawardena T, Corballis N, Bhalraam U, Gilbert T, Maart C, Richardson P, Ryding A, Sarev T, Sawh C, Sulfi S, Wickramarachchi U, Wistow T, Mohamed MO, Mamas MA, Vassiliou VS, Eccleshall SC. Paclitaxel drug-coated balloon-only angioplasty for de novo coronary artery disease in elective clinical practice. Clin Res Cardiol. 2023 Sep; 112(9):1186-1193.
-
Vishnevsky A, Savage MP, Fischman DL. Case of the Disappearing Metallic Stent. JACC Cardiovasc Interv. 2018 09 10; 11(17):1783-1784.
-
Olier I, Sirker A, Hildick-Smith DJR, Kinnaird T, Ludman P, de Belder MA, Baumbach A, Byrne J, Rashid M, Curzen N, Mamas MA. Association of different antiplatelet therapies with mortality after primary percutaneous coronary intervention. Heart. 2018 10; 104(20):1683-1690.
-
Noman A, Balasubramaniam K, Alhous MHA, Lee K, Jesudason P, Rashid M, Mamas MA, Zaman AG. Mortality after percutaneous coronary revascularization: Prior cardiovascular risk factor control and improved outcomes in patients with diabetes mellitus. Catheter Cardiovasc Interv. 2017 Jun 01; 89(7):1195-1204.
-
Farooq V, Mamas MA, Fraser DG, El-Omar M, Clarke B, Fath-Ordoubadi F. Serial optical coherence tomography of drug-eluting stent in-stent restenosis treated with the Absorb bioresorbable scaffold: an effective treatment? EuroIntervention. 2015 Mar 22; 10(11):e1.
-
Fanari Z, Weiss SA, Zhang W, Sonnad SS, Weintraub WS. Comparison of percutaneous coronary intervention with drug eluting stents versus coronary artery bypass grafting in patients with multivessel coronary artery disease: Meta-analysis of six randomized controlled trials. Cardiovasc Revasc Med. 2015 Mar; 16(2):70-7.
-
Mamas MA, Foin N, Abunassar C, Khan MA, Di Mario C, Fraser DG. Stent fracture: Insights on mechanisms, treatments, and outcomes from the food and drug administration manufacturer and user facility device experience database. Catheter Cardiovasc Interv. 2014 Jun 01; 83(7):E251-9.
-
Waseda K, Hasegawa T, Ako J, Honda Y, Grube E, Whitbourn R, Ormiston J, O'Shaughnessy CD, Henry TD, Overlie P, Schwartz LB, Sudhir K, Chevalier B, Gray WA, Yeung AC, Fitzgerald PJ. Comparison of vascular response to zotarolimus-eluting stent vs paclitaxel-eluting stent implantation: pooled IVUS results from the ZoMaxx I and II trials. Circ J. 2010 Nov; 74(11):2334-9.
-
Contractor H, Mamas M, Fraser DG. Angiographic time course of in-stent restenosis with zotarolimus drug-eluting stents. Can J Cardiol. 2008 Jul; 24(7):e45.
-
Brener SJ, Milford-Beland S, Roe MT, Bhatt DL, Weintraub WS, Brindis RG. Culprit-only or multivessel revascularization in patients with acute coronary syndromes: an American College of Cardiology National Cardiovascular Database Registry report. Am Heart J. 2008 Jan; 155(1):140-6.